Farnesylated tetrahydro-naphthalenols as hypolipidemic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546322, 560138, 514356, A61K 31215, C07C 69017

Patent

active

052965082

ABSTRACT:
The invention relates to novel farnesylated tetrahydro-naphthalenols, that inhibit HMGR activity which results in a decrease in serum total cholesterol, a decrease in LDL cholesterol levels, and inhibition of LDL oxidation. The farnesylated tetrahydro-naphthalenols of the present invention are thus useful for cholesterol/lipid lowering in cases of hypercholesterolemia, hyperlipidemia, and atherosclerosis.

REFERENCES:
patent: 4680310 (1987-07-01), Hengartner et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Farnesylated tetrahydro-naphthalenols as hypolipidemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Farnesylated tetrahydro-naphthalenols as hypolipidemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Farnesylated tetrahydro-naphthalenols as hypolipidemic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-437424

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.